APC truncation and increased β-catenin levels in a human breast cancer cell line

Mutations in the Adenomatous Polyposis Coli (APC) tumor suppressor gene or the β-catenin gene are present in most colon cancers and less frequently in other tumor types. In this study, we screened 24 human breast cancer cell lines and three immortalized human breast epithelial cell lines for alterat...

Full description

Saved in:
Bibliographic Details
Published in:Carcinogenesis (New York) 2000-07, Vol.21 (7), p.1453-1456
Main Authors: Schlosshauer, Peter W., Brown, Stephen A., Eisinger, Katarina, Yan, Qingyou, Guglielminetti, Enrica R., Parsons, Ramon, Ellenson, Lora Hedrick, Kitajewski, Jan
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutations in the Adenomatous Polyposis Coli (APC) tumor suppressor gene or the β-catenin gene are present in most colon cancers and less frequently in other tumor types. In this study, we screened 24 human breast cancer cell lines and three immortalized human breast epithelial cell lines for alterations in β- and γ-catenin and APC by western blotting, protein truncation assay and DNA sequence analysis. In one cell line (DU 4475), an APC mutation was identified (E1577stop) that resulted in expression of truncated APC. This mutation was associated with elevated cytosolic β-catenin levels, probably due to loss of APC function, as in colon cancers. No mutations were found in exon 3 of the β- or γ-catenin genes. We conclude that APC mutations and β-catenin upregulation may occur with low frequency in human breast cancer cells.
ISSN:0143-3334
1460-2180
DOI:10.1093/carcin/21.7.1453